How do you compare automated sample preparation systems before purchasing in 2026?

To compare automated sample preparation systems before purchasing, evaluate each platform across five core criteria: degree of automation, solvent consumption, supported sample matrices, cross-contamination risk, and vendor support quality. The right system depends on the contaminants you analyze, the throughput your laboratory requires, and the regulatory standards you must meet. The questions below walk through each of these evaluation dimensions in detail.

What criteria matter most when evaluating automated sample preparation systems?

The most important criteria when evaluating automated sample preparation systems are automation level, solvent efficiency, matrix compatibility, contamination control, and total cost of ownership. Laboratories analyzing persistent organic pollutants such as dioxins, PCBs, or PFAS should also assess whether a system supports the specific regulatory methods, such as EPA or CEN standards, required for their reporting obligations.

Beyond technical specifications, practical criteria carry significant weight in a purchasing decision. Consider how quickly a system can be integrated into your existing workflow, whether it requires dedicated operator supervision during runs, and how much training staff will need before achieving reliable results. A system that looks capable on paper but demands constant manual intervention defeats the purpose of laboratory automation.

Total cost of ownership is frequently underestimated. Purchase price is only part of the equation: factor in consumable costs, solvent procurement and disposal, maintenance contracts, and the cost of downtime if a system fails during a high-volume period. Laboratories that process large batches regularly will find that even modest differences in per-sample solvent use add up to substantial savings or costs over a year.

How do fully automated systems differ from semi-automated sample prep platforms?

Fully automated sample preparation systems execute the entire preparation sequence, extraction, cleanup, and concentration, without operator intervention once the run is initiated. Semi-automated platforms require manual steps at one or more stages, such as transferring samples between modules or manually initiating solvent washes. The practical difference is throughput capacity, reproducibility, and the amount of skilled labor time each approach consumes.

In a fully automated workflow, the system handles timing, solvent volumes, valve switching, and fraction collection according to a pre-programmed method. This removes the variability introduced by different operators performing the same steps slightly differently, which is particularly important for regulated analyses where method reproducibility must be documented for accreditation purposes.

Semi-automated systems can be a reasonable starting point for laboratories with lower sample volumes or tighter budgets, but they introduce a ceiling on throughput and a floor on reproducibility. As regulatory demands increase and sample numbers grow, the limitations of semi-automation become more apparent. Laboratories planning for growth or seeking ISO 17025 accreditation typically find that fully automated platforms deliver a stronger long-term return.

What role does solvent consumption play in choosing a sample prep system?

Solvent consumption is a critical purchasing criterion because it directly affects laboratory operating costs, operator safety, and environmental compliance. Systems that reduce organic solvent use to less than 100 ml per sample, and eliminate the need for hazardous solvents like dichloromethane, offer measurable advantages in all three areas. As sustainability requirements tighten across Europe and North America, low-solvent platforms are increasingly preferred by both laboratories and their clients.

High solvent consumption creates cascading costs. Procurement, storage, and disposal of organic solvents are all regulated activities that require dedicated infrastructure and documentation. Laboratories using large solvent volumes per sample face greater exposure risk for staff, higher waste disposal fees, and more complex safety compliance obligations. Reducing solvent use is not simply an environmental gesture: it is a direct operational efficiency gain.

When comparing systems, ask vendors for documented per-sample solvent figures under real operating conditions, not best-case scenarios. Also confirm which solvents the system requires. Some platforms that appear solvent-efficient still rely on dichloromethane for certain cleanup steps, which reintroduces handling and disposal challenges. Systems designed from the ground up to operate without dichloromethane represent a more complete solution for laboratories prioritizing green analytical chemistry.

Which sample matrices and contaminant types should a system support?

A sample preparation system should support every matrix your laboratory currently analyzes, plus those you are likely to add within the next two to three years. For environmental contaminant analysis, this typically means food, feed, soil, water, sludge, sewage, and air. Contaminant coverage should include dioxins, PCBs, PBDEs, PFAS, pesticides, PAHs, and, depending on your scope, emerging contaminants such as PCNs and hormones.

Matrix compatibility is not always obvious from a product brochure. A system may be validated for water and soil but perform poorly with lipid-rich food matrices that require more aggressive cleanup. Ask vendors for application notes or published validation data covering the specific matrix-contaminant combinations relevant to your work. Peer-reviewed publications and conference papers provide stronger evidence than internal marketing documents.

Contaminant scope matters especially for laboratories that anticipate regulatory expansion. PFAS monitoring requirements, for example, have grown substantially in recent years and are expected to continue expanding. A system that handles PFAS extraction alongside legacy POPs gives laboratories the flexibility to respond to new regulatory demands without investing in a separate platform. high-capacity SPE platforms designed for PFAS, pesticides, and SVOCs illustrate how a single system can cover a broad analytical scope without sacrificing performance on any individual contaminant class.

How do you assess cross-contamination risk across competing platforms?

Cross-contamination risk in automated sample preparation systems is determined by whether samples come into direct contact with shared system components between runs. Systems where the sample never contacts the instrument’s internal flow path, because disposable cartridges or isolated pathways handle all sample contact, eliminate carryover risk by design. Systems that rely on solvent flushing between samples to clean shared surfaces carry an inherent residual risk that must be validated and monitored.

When evaluating competing platforms, ask each vendor to explain specifically how carryover is prevented. Request validation data showing carryover performance across the contaminant classes you analyze, particularly for high-sensitivity targets like dioxins and PFAS where even trace contamination can invalidate results. If a vendor cannot provide this data, that is itself a meaningful answer.

Flow path materials also matter for certain contaminant types. PFAS analysis requires flow paths that are completely free of fluoropolymers, including PTFE (Teflon), because these materials can leach PFAS compounds into samples and produce false positives. Systems built with fully inert, Teflon-free flow paths are specifically designed to address this problem and are worth prioritizing for any laboratory conducting PFAS analysis. Confirm material specifications in writing before purchasing.

What should laboratories ask vendors before finalizing a purchasing decision?

Before finalizing a purchase, laboratories should ask vendors a structured set of questions covering validation evidence, regulatory compliance, installation support, training, and ongoing service. The goal is to move beyond product features and understand what the vendor relationship will look like after the system is delivered. A technically capable system supported by a weak vendor is a significant operational risk.

The most important questions to ask include:

Which EPA and CEN methods has this system been validated for, and can you provide the supporting documentation?
What is the per-sample solvent consumption under standard operating conditions for our target matrices?
How is cross-contamination prevented, and what carryover data is available for our contaminant classes?
What does installation include: is pre-installation programming and application testing part of the package?
What training is provided, and in what format (on-site, remote, or written)?
What is the typical response time for technical support, and is a service contract available?
Can the system be configured or expanded to handle additional matrices or contaminants in the future?

References from existing users in comparable laboratory settings are valuable. A vendor willing to connect you with reference customers is demonstrating confidence in their product’s real-world performance. Vendors who are reluctant to provide references or application-specific validation data should be treated with caution during the automated cleanup system evaluation process.

Finally, clarify the scope of pre-sales technical support. Reputable vendors will invest time in understanding your specific application before recommending a system, rather than defaulting to their most popular product regardless of fit.

How DSP-Systems helps you compare and choose the right automated sample preparation system

DSP-Systems supports laboratories across Europe and North America in selecting, implementing, and operating automated sample preparation systems for environmental contaminant analysis. Rather than offering a single product, DSP-Systems provides a portfolio of validated platforms matched to specific analytical needs:

The GO-EHT fully automated cleanup system for dioxins, PCBs, PBDEs, and PCNs across food, feed, soil, water, and air matrices, with solvent consumption below 100 ml per sample and no dichloromethane required
The SPE2000 for high-throughput extraction of PFAS, pesticides, hormones, SVOCs, and PAHs, processing up to 80 samples per run
The AutoEmpore for large-volume water sample extraction with flexible disk and cartridge configurations
The SER-158 solvent extractor for solid and semi-solid samples, fully compatible with GO-EHT cleanup workflows
Pre-installation programming, SPE application testing, and configuration in line with EPA and CEN standards as part of the delivery process
Method development support, training courses, and ongoing technical assistance for laboratories building or scaling internal capabilities

If you are currently evaluating automated sample preparation systems and want guidance tailored to your specific matrices, contaminants, and regulatory requirements, contact DSP-Systems directly to discuss your laboratory’s needs.

Veelgestelde vragen

How long does it typically take to integrate an automated sample preparation system into an existing laboratory workflow?

Integration timelines vary depending on the complexity of your existing workflow and the system you select, but most laboratories can expect a period of four to twelve weeks from delivery to routine operation. This includes installation, method programming, staff training, and internal validation runs. Vendors who offer pre-installation programming and application testing as part of the delivery process — rather than leaving configuration to the end user — significantly shorten this timeline. Asking your vendor exactly what is included in the commissioning phase before signing a contract will help you set realistic expectations and avoid unexpected delays.

Can a single automated sample preparation system handle multiple regulatory methods, or do we need separate platforms for different standards?

Many modern fully automated platforms can be configured to run multiple regulatory methods — such as EPA 1613, EPA 8290, or CEN standards — on the same instrument by switching between pre-programmed methods stored in the system’s software. However, the extent of multi-method flexibility varies significantly between platforms, and validation must be performed separately for each method. When evaluating systems, ask vendors to demonstrate that the platform has been validated for your specific method set, not just that it is theoretically capable of running them. A system validated across a broad range of EPA and CEN methods reduces the need for separate platforms and future capital investment.

What are the most common mistakes laboratories make when comparing automated sample prep systems?

The most common mistake is evaluating systems primarily on purchase price while underestimating total cost of ownership, particularly solvent consumption, consumable costs, and maintenance contracts. A second frequent error is accepting vendor-supplied performance data at face value without requesting validation evidence for your specific matrix-contaminant combinations — brochure figures are often generated under ideal conditions that may not reflect your laboratory’s real workload. Finally, many laboratories overlook scalability, selecting a system that meets current throughput needs but cannot accommodate growth in sample volume or the addition of new contaminant classes, leading to a second capital investment sooner than anticipated.

Is ISO 17025 accreditation achievable with a semi-automated sample preparation workflow, or is full automation required?

ISO 17025 accreditation is technically achievable with semi-automated workflows, but the path is considerably more demanding because accreditation bodies require documented evidence of method reproducibility and operator-independent performance. Semi-automated steps introduce variability that must be controlled and demonstrated through extensive inter-operator validation studies. Fully automated systems, where the instrument executes every step according to a fixed, pre-programmed method, make it substantially easier to generate the reproducibility data accreditation assessors require. For laboratories actively pursuing or maintaining ISO 17025 status, fully automated platforms represent a more defensible and audit-ready approach.

How do we validate that a new automated system produces results equivalent to our existing manual or semi-automated method?

Method equivalency validation typically involves running a set of reference samples — ideally certified reference materials or well-characterized in-house standards — in parallel on both the existing and new system, then comparing recovery rates, precision, and detection limits against your acceptance criteria. Regulatory guidance documents such as EPA method validation protocols or SANTE guidelines for pesticide residues provide structured frameworks for conducting this comparison. Most reputable vendors will support this process by providing application notes, reference data, and on-site technical assistance during the transition period. Building the equivalency study into your implementation timeline before decommissioning the old workflow is strongly recommended.

What should we do if our laboratory analyzes an unusual or highly complex matrix that a vendor has not previously validated their system for?

Start by requesting any application data the vendor has for the closest comparable matrix, and ask whether their technical team has experience developing methods for similar sample types. Reputable vendors will typically offer a feasibility assessment or application development service, sometimes including trial runs on your actual samples before purchase. If no existing data is available, factor in the time and cost of in-house method development as part of your total cost of ownership calculation. Choosing a platform with an open, flexible method programming environment — rather than a locked, fixed-method system — gives your laboratory the best chance of successfully developing and validating a new application without vendor dependency.

How often do automated sample preparation systems require maintenance, and how does downtime affect laboratory planning?

Maintenance frequency depends on the system design, sample throughput, and the solvents and matrices being processed, but most platforms require scheduled preventive maintenance at least once or twice per year, plus periodic replacement of consumable components such as seals, valves, and tubing. Unplanned downtime is the greater operational risk: a system failure during a high-volume period can delay sample reporting and create compliance issues for time-sensitive regulatory submissions. When evaluating vendors, ask specifically about mean time between failures, typical repair turnaround times, and whether loaner equipment or remote diagnostics are available under a service contract. Laboratories with high throughput or strict reporting deadlines should treat service contract terms as a critical purchasing criterion, not an afterthought.

Gerelateerde artikelen

Deze inhoud is gegenereerd met behulp van AI en kan fouten bevatten.